Biolex Therapeutics' Series D Round

Biolex Therapeutics raised a round of funding on October 13, 2008.

Biolex Therapeutics is a clinical-stage biopharmaceutical company that uses the LEX System to develop follow-on biologics, hard-to-make therapeutic proteins and monoclonal antibodies that have been op…

Articles about Biolex Therapeutics' Series D Round: